TUSC3 and cancer: In addition, TUSC3 expression was down-regulated in late stage cancers, and low TUSC3 expression was significantly associated with shorter TTP in prostate cancer, as well as decreased survival in several TCGA cancer sets (Supplementary Figure 2).